AUG Therapeutics
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| An Extension Study Assessing the Safety and Efficacy of AVTX-803 in Subjects With Leukocyte Adhesion Deficiency Type II (NCT05754450) | AUG Therapeutics | 2023-04-10 |
| A Study to Evaluate Efficacy and Safety of AVTX-803 in Patients With Leukocyte Adhesion Deficiency Type II (NCT05462587) | AUG Therapeutics | 2022-07-28 |
Track AUG Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.